e-BioMatrix PostMarket Registry

NCT01289002 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5652

Last updated 2019-05-06

No results posted yet for this study

Summary

The purpose of this registry is to capture clinical data of the BioMatrix™ and BioMatrix Flex™ (Biolimus A9™-Eluting) stent systems in relation to safety and effectiveness.

Conditions

Sponsors & Collaborators

  • Biosensors Europe SA

    lead INDUSTRY

Principal Investigators

  • Philip Urban, MD · Hôpital de la Tour

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2012-09-30
Completion
2014-09-30

Countries

  • Austria
  • Czechia
  • Denmark
  • France
  • Germany
  • Ireland
  • Jordan
  • Latvia
  • Lithuania
  • Morocco
  • Poland
  • Portugal
  • Russia
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01289002 on ClinicalTrials.gov